You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
ST雲投(002200.SZ):聯合體預中標雲南省重大傳染病救治能力和疾控機構核心能力提升工程工程總承包項目
格隆匯 08-28 23:45

格隆匯 8 月 28日丨ST雲投(002200.SZ)公佈,近日,公司經查詢雲南省公共資源交易中心發佈的《雲南省重大傳染病救治能力和疾控機構核心能力提升工程工程總承包(FEPC)中標候選人公示》獲悉,經公開招標,公司與雲南雲投建設有限公司(聯合體牽頭人)、雲南工程建設總承包股份有限公司、雲南建投第七建設有限公司、中鐵十一局集團有限公司等21家單位作為聯合體,被確定為“雲南省重大傳染病救治能力和疾控機構核心能力提升工程工程總承包(FEPC)”的第一中標候選人。項目招標人為雲南省社會事業發展有限公司,招標代理機構為雲南西南招標有限公司。

根據《招標文件》顯示,“雲南省重大傳染病救治能力和疾控機構核心能力提升工程工程總承包(FEPC)”項目主要建設範圍包括雲南省內傳染病醫院新建項目、縣級綜合醫院改造項目和其他醫院核酸能力提升、省級區域性國際疾控中心新建項目及其他縣、市、區疾控中心改造項目。“雲南省重大傳染病救治能力和疾控機構核心能力提升工程工程總承包(FEPC)”項目總投資估算80.14億元,其中:(1)雲南省傳染病救治能力提升工程,計劃靜態投資68.56億元,包括新建項目49.14億元、縣級綜合醫院改造項目15.52億元,三級中醫、婦幼、綜合醫院核酸能力提升項目2.55億元,定點、方艙、移動醫院建設項目1.35億元;(2)雲南省疾控機構核心能力提升項目,計劃靜態投資11.58億元,包括新建項目2.6億元,改造項目7.03億,衞生應急裝備物資1.95億。

依據投標文件,公司作為聯合體成員之一,主要實施部分醫院改造及疾控中心改造項目,公司實施部分的金額尚須與聯合體各單位協商,暫不明確,具體以相關合同或協議約定為準。項目若能順利實施,將對公司2020年及未來年度經營業績產生積極的影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account